Cargando…

Transcriptome Analysis Identifies ALCAM Overexpression as a Prognosis Biomarker in Laryngeal Squamous Cell Carcinoma

Background: Laryngeal squamous cell carcinoma (LSCC) is one of the most incident tumors in the world, especially in developing countries, such as Brazil. Different from other tumors, LSCC prognosis did not improve during the past four decades. Therefore, the objective of this study was to develop bi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nicolau-Neto, Pedro, de Souza-Santos, Paulo Thiago, Severo Ramundo, Mariana, Valverde, Priscila, Martins, Ivanir, Costa Santos, Izabella, Dias, Fernando, de Almeida Simão, Tatiana, Ribeiro Pinto, Luis Felipe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072229/ https://www.ncbi.nlm.nih.gov/pubmed/32085563 http://dx.doi.org/10.3390/cancers12020470

Ejemplares similares

Upper Aerodigestive Tract Squamous Cell Carcinomas Show Distinct Overall DNA Methylation Profiles and Different Molecular Mechanisms behind WNT Signaling Disruption
por: Soares-Lima, Sheila Coelho, et al.
Publicado: (2021)

Alterations in epidermal growth factor receptors 1 and 2 in esophageal squamous cell carcinomas
por: Gonzaga, Isabela Martins, et al.
Publicado: (2012)

ALCAM-EGFR interaction regulates myelomagenesis
por: Luo, Hongmei, et al.
Publicado: (2021)

Prognostic Significance of Activated Leukocyte Cell Adhesion Molecule (ALCAM) in Association with Promoter Methylation of the ALCAM Gene in Breast Cancer
por: Jeong, Young Ju, et al.
Publicado: (2018)

Mutations, Differential Gene Expression, and Chimeric Transcripts in Esophageal Squamous Cell Carcinoma Show High Heterogeneity()
por: Souza-Santos, Paulo Thiago de, et al.
Publicado: (2018)

ALCAM Makes It All Calm by Inhibiting Apoptosis
por: Chen, Peter, et al.
Publicado: (2022)

HMGA2 overexpression plays a critical role in the progression of esophageal squamous carcinoma
por: Palumbo, Antonio, et al.
Publicado: (2016)

ALCAM regulates multiple myeloma chemoresistant side population
por: Wang, Fangfang, et al.
Publicado: (2022)

TFF1 hypermethylation and decreased expression in esophageal squamous cell carcinoma and histologically normal tumor surrounding esophageal cells
por: Gonzaga, Isabela Martins, et al.
Publicado: (2017)

ALCAM (CD166) Expression and Serum Levels in Pancreatic Cancer
por: Tachezy, Michael, et al.
Publicado: (2012)

Different Subcellular Localization of ALCAM Molecules in Neuroblastoma: Association with Relapse
por: Corrias, Maria Valeria, et al.
Publicado: (2010)

Increase of ALCAM and VCAM-1 in the plasma predicts the Alzheimer’s disease
por: Chen, Jian, et al.
Publicado: (2023)

MET overexpression and intratumor heterogeneity in esophageal squamous cell carcinoma
por: Abboud, H.S., et al.
Publicado: (2021)

Laryngeal Leishmaniasis
por: Moraes, Bruno Teixeira de, et al.
Publicado: (2012)

ALCAM(+) stromal cells: role in giant cell tumor of bone progression
por: Zhou, Zhenhua, et al.
Publicado: (2018)

Optimization and Characterization of Novel ALCAM-Targeting Antibody Fragments for Transepithelial Delivery
por: Bauer, Aline, et al.
Publicado: (2023)

UBE2C Is a Transcriptional Target of the Cell Cycle Regulator FOXM1
por: Nicolau-Neto, Pedro, et al.
Publicado: (2018)

Esophageal squamous cell carcinoma transcriptome reveals the effect of FOXM1 on patient outcome through novel PIK3R3 mediated activation of PI3K signaling pathway
por: Nicolau-Neto, Pedro, et al.
Publicado: (2018)

Essential role for ALCAM gene silencing in megakaryocytic differentiation of K562 cells
por: Tan, Fang, et al.
Publicado: (2010)

ALCAM Regulates Motility, Invasiveness, and Adherens Junction Formation in Uveal Melanoma Cells
por: Jannie, Karry M., et al.
Publicado: (2012)

Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer
por: Tan, Fang, et al.
Publicado: (2014)

Depending on Its Nano-Spacing, ALCAM Promotes Cell Attachment and Axon Growth
por: Thelen, Karsten, et al.
Publicado: (2012)

Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients
por: Donizy, Piotr, et al.
Publicado: (2015)

ALCAM/CD166 Is Involved in the Binding and Uptake of Cancer-Derived Extracellular Vesicles
por: Cardeñes, Beatriz, et al.
Publicado: (2022)

Multi-cancer V-ATPase molecular signatures: A distinctive balance of subunit C isoforms in esophageal carcinoma
por: Couto-Vieira, Juliana, et al.
Publicado: (2020)

Head and Neck Cancers Are Not Alike When Tarred with the Same Brush: An Epigenetic Perspective from the Cancerization Field to Prognosis
por: Camuzi, Diego, et al.
Publicado: (2021)

Meta-analysis indicating that high ALCAM expression predicts poor prognosis in colorectal cancer
por: Zhang, Yeqing, et al.
Publicado: (2017)

ALCAM Mediates DC Migration Through Afferent Lymphatics and Promotes Allospecific Immune Reactions
por: Willrodt, Ann-Helen, et al.
Publicado: (2019)

Elevated ALCAM Expression Associated with Endotypes and Postoperative Recurrence in Chronic Rhinosinusitis with Nasal Polyps
por: Zhang, Hua, et al.
Publicado: (2022)

The CD6/ALCAM pathway promotes lupus nephritis via T cell–mediated responses
por: Chalmers, Samantha A., et al.
Publicado: (2022)

ALCAM: A Novel Surface Marker on EpCAM(low) Circulating Tumor Cells
por: Signorelli, Rossana, et al.
Publicado: (2022)

Laryngeal hemangioma
por: Martins, Regina Helena Garcia, et al.
Publicado: (2015)

CD166/ALCAM Expression Is Characteristic of Tumorigenicity and Invasive and Migratory Activities of Pancreatic Cancer Cells
por: Fujiwara, Kenji, et al.
Publicado: (2014)

Activated leukocyte cell adhesion molecule (ALCAM or CD166) modulates bone phenotype and hematopoiesis
por: Hooker, R.A., et al.
Publicado: (2015)

Alternative splicing of ALCAM enables tunable regulation of cell-cell adhesion through differential proteolysis
por: Hebron, Katie E., et al.
Publicado: (2018)

ALCAM (CD166) as a gene expression marker for human mesenchymal stromal cell characterisation
por: Brinkhof, Bas, et al.
Publicado: (2020)

Importance of activated leukocyte cell adhesion molecule (ALCAM) in prostate cancer progression and metastatic dissemination
por: Sanders, Andrew J., et al.
Publicado: (2019)

A novel technology for home monitoring of lupus nephritis that tracks the pathogenic urine biomarker ALCAM
por: Lei, Rongwei, et al.
Publicado: (2022)

Alcam-a and Pdgfr-α are essential for the development of sclerotome-derived stromal cells that support hematopoiesis
por: Murayama, Emi, et al.
Publicado: (2023)

Shed urinary ALCAM is an independent prognostic biomarker of three-year overall survival after cystectomy in patients with bladder cancer
por: Egloff, Shanna A. Arnold, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_j2d73tjupest54siv4h7d3tj58